374 related articles for article (PubMed ID: 11303591)
1. Urinary phytoestrogens and postmenopausal breast cancer risk.
den Tonkelaar I; Keinan-Boker L; Veer PV; Arts CJ; Adlercreutz H; Thijssen JH; Peeters PH
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):223-8. PubMed ID: 11303591
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai.
Dai Q; Franke AA; Jin F; Shu XO; Hebert JR; Custer LJ; Cheng J; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):815-21. PubMed ID: 12223424
[TBL] [Abstract][Full Text] [Related]
3. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
Dai Q; Franke AA; Yu H; Shu XO; Jin F; Hebert JR; Custer LJ; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):497-502. PubMed ID: 12814993
[TBL] [Abstract][Full Text] [Related]
4. Plasma enterolactone and genistein and the risk of premenopausal breast cancer.
Piller R; Chang-Claude J; Linseisen J
Eur J Cancer Prev; 2006 Jun; 15(3):225-32. PubMed ID: 16679865
[TBL] [Abstract][Full Text] [Related]
5. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.
Pietinen P; Stumpf K; Männistö S; Kataja V; Uusitupa M; Adlercreutz H
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):339-44. PubMed ID: 11319174
[TBL] [Abstract][Full Text] [Related]
6. Phytoestrogens and thyroid cancer risk: the San Francisco Bay Area thyroid cancer study.
Horn-Ross PL; Hoggatt KJ; Lee MM
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):43-9. PubMed ID: 11815400
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
8. Plasma enterolactone and breast cancer incidence by estrogen receptor status.
Olsen A; Knudsen KE; Thomsen BL; Loft S; Stripp C; Overvad K; Møller S; Tjønneland A
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2084-9. PubMed ID: 15598765
[TBL] [Abstract][Full Text] [Related]
9. Urinary and serum concentrations of seven phytoestrogens in a human reference population subset.
Valentín-Blasini L; Blount BC; Caudill SP; Needham LL
J Expo Anal Environ Epidemiol; 2003 Jul; 13(4):276-82. PubMed ID: 12923554
[TBL] [Abstract][Full Text] [Related]
10. Urinary phytoestrogens and risk of prostate cancer in Jamaican men.
Jackson MD; McFarlane-Anderson ND; Simon GA; Bennett FI; Walker SP
Cancer Causes Control; 2010 Dec; 21(12):2249-57. PubMed ID: 20924663
[TBL] [Abstract][Full Text] [Related]
11. Comparison of plasma and urinary phytoestrogens in Japanese and Finnish women by time-resolved fluoroimmunoassay.
Uehar M; Arai Y; Watanabe S; Adlercreutz H
Biofactors; 2000; 12(1-4):217-25. PubMed ID: 11216489
[TBL] [Abstract][Full Text] [Related]
12. Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period.
Zeleniuch-Jacquotte A; Adlercreutz H; Akhmedkhanov A; Toniolo P
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):885-9. PubMed ID: 9796633
[TBL] [Abstract][Full Text] [Related]
13. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products.
Hutchins AM; Slavin JL; Lampe JW
J Am Diet Assoc; 1995 May; 95(5):545-51. PubMed ID: 7722188
[TBL] [Abstract][Full Text] [Related]
14. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
15. Plasma phytoestrogens and subsequent breast cancer risk.
Verheus M; van Gils CH; Keinan-Boker L; Grace PB; Bingham SA; Peeters PH
J Clin Oncol; 2007 Feb; 25(6):648-55. PubMed ID: 17200150
[TBL] [Abstract][Full Text] [Related]
16. Case-control study of phyto-oestrogens and breast cancer.
Ingram D; Sanders K; Kolybaba M; Lopez D
Lancet; 1997 Oct; 350(9083):990-4. PubMed ID: 9329514
[TBL] [Abstract][Full Text] [Related]
17. Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada).
Cotterchio M; Boucher BA; Kreiger N; Mills CA; Thompson LU
Cancer Causes Control; 2008 Apr; 19(3):259-72. PubMed ID: 17992574
[TBL] [Abstract][Full Text] [Related]
18. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
19. Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study.
Sonestedt E; Borgquist S; Ericson U; Gullberg B; Olsson H; Adlercreutz H; Landberg G; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3241-51. PubMed ID: 18990767
[TBL] [Abstract][Full Text] [Related]
20. Urinary estrogen metabolites and breast cancer: a case-control study.
Kabat GC; Chang CJ; Sparano JA; Sepkovie DW; Hu XP; Khalil A; Rosenblatt R; Bradlow HL
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):505-9. PubMed ID: 9232337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
